Drug Discovery World
SEPTEMBER 3, 2024
Researchers from Flinders University and University of South Australia have unveiled a promising new strategy that could be used to treat the most aggressive forms of prostate cancer. This study, published in British Journal of Cancer , explores the role of a novel drug, CDKI-73, to tackle drug-resistant prostate cancer that defies conventional therapies.
Science Daily: Pharmacology News
SEPTEMBER 3, 2024
We all know the adage, 'You can't teach an old dog new tricks.' As we age, our ability to learn new skills, like mastering a foreign language or picking up a musical instrument, seems to fade. The culprit? A decline in brain plasticity - the brain's capacity to rewire itself and adapt to new challenges. But what if we could rewind the clock on this age-related decline?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
SEPTEMBER 3, 2024
Grit Biotechnology has received investigational new drug (IND) approval from the US Food and Drug Administration (FDA) for its genetically engineered tumour-infiltrating lymphocyte (TIL) product GT201. The therapy is now approved by both the FDA and China Center for Drug Evaluation (CDE) to enter clinical trials in both countries for advanced solid tumour patients.
Science Daily: Pharmacology News
SEPTEMBER 3, 2024
Around 4 billion years ago, an asteroid hit the Jupiter moon Ganymede. Now, a researcher realized that the Solar System's biggest moon's axis has shifted as a result of the impact, which confirmed that the asteroid was around 20 times larger than the one that ended the age of the dinosaurs on Earth, and caused one of the biggest impacts with clear traces in the Solar System.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Discovery World
SEPTEMBER 3, 2024
Semaglutide has been found to reduce the rates of all-cause death, including as a result of Covid-19, in those who are overweight or have obesity and established cardiovascular disease without diabetes. The findings were published in JACC , the journal of the American College of Cardiology and presented at the European Society of Cardiology (ESC) Conference 2024 in London.
BioPharma Drive: Drug Pricing
SEPTEMBER 3, 2024
While results from two after-the-fact analyses were “reassuring,” outside experts urged “continued vigilance” to ensure GLP-1 drugs don’t worsen problems in people with preexisting mental health conditions.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
SEPTEMBER 3, 2024
TUESDAY, Sept. 3, 2024 -- New England is on alert following one death and a handful of infections of eastern equine encephalitis (EEE) virus.A New Hampshire resident died after contracting EEE, which is spread by mosquito bites, according to a.
Science Daily: Pharmacology News
SEPTEMBER 3, 2024
Over billions of years, the universe's stars and galaxies shined their light into space, leaving behind an imperceptibly faint night light known as the cosmic optical background. NASA's New Horizons spacecraft has traveled to the edge of Earth's solar system and captured the most accurate measurement of this glow to date.
Drugs.com
SEPTEMBER 3, 2024
TUESDAY, Sept. 3, 2024 -- The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy.But a new study rules out one possible problem -- using semaglutide.
Drug Patent Watch
SEPTEMBER 3, 2024
Scaling your business with a Contract Development and Manufacturing Organization (CDMO) is crucial for biopharmaceutical companies seeking to expedite the transition from preclinical development to clinical manufacturing. CDMOs play a vital role in providing expertise in process development and scale-up manufacturing, allowing biotech companies to adapt to changing market dynamics and client needs.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
SEPTEMBER 3, 2024
TUESDAY, Sept. 3, 2024 -- An experimental “smart mask” can check a person’s breath to check their health, researchers report.Fitted with biosensors, the simple paper mask could be used to track respiratory ailments, kidney disease and a number of ot.
Drugs.com
SEPTEMBER 3, 2024
TUESDAY, Sept. 3, 2024 -- A significant number of women stop getting regular mammograms after being frightened by a “false positive” scan that incorrectly suggests they have breast cancer, a new study finds.About 77% of women return for a regular ma.
FDA Law Blog: Biosimilars
SEPTEMBER 3, 2024
By Véronique Li, Senior Medical Device Regulation Expert & Jeffrey N. Gibbs — Thank you to readers of this blog. We received incredible feedback on our August 19 post analyzing the number of decision summaries that have been posted for De Novos. We are happy to report that fifteen new decision summaries have been posted as of August 28. Notably, two decision summaries were posted for De Novos that had been granted in 2020 and two were posted for De Novos granted this year.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
BioPharma Drive: Drug Pricing
SEPTEMBER 3, 2024
The company's value jumped by several billion dollars as trial results showed its experimental shot could match and, in some cases, even outperform Pfizer's market-leading Prevnar 20.
Drugs.com
SEPTEMBER 3, 2024
TUESDAY, Sept. 3, 2024 -- Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health.But they still need to eat a high-quality diet if they want to maintain their well-being while they shed pounds, s.
BioPharma Drive: Drug Pricing
SEPTEMBER 3, 2024
Tolebrutinib, which Sanofi acquired in a $3.7 billion deal, failed two studies in people with relapsing disease, but succeeded in a type of multiple sclerosis that has no approved therapies.
Drugs.com
SEPTEMBER 3, 2024
TUESDAY, Sept. 3, 2024 -- Brain tumors in young children are rare, but those who survive them can lag in school for years afterwards, new research shows.For those families that can afford it, intervening when kids are still in the preschool years.
BioPharma Drive: Drug Pricing
SEPTEMBER 3, 2024
The Phase 2 results for Recursion’s cerebral cavernous malformation treatment are the first in a series of important trial readouts for the high-profile “techbio” company.
Drugs.com
SEPTEMBER 3, 2024
TUESDAY, Sept. 3, 2024 -- Cases of menopause occurring before the age of 40 can be a major cause of distress and discomfort for women, but researchers now believe they've homed in on the condition's genetic cause.A team at deCODE genetics sought to.
BioPharma Drive: Drug Pricing
SEPTEMBER 3, 2024
Pharma companies can thrive in 2024 by leveraging digital intelligence to anticipate trends, analyze sentiment, and engage audiences. Discover how data-driven insights drive success.
Drugs.com
SEPTEMBER 3, 2024
TUESDAY, Sept. 3, 2024 -- A survey of Australian adolescents finds those who are experiencing depressive symptoms have double the risk of taking up vaping.“In the short term, nicotine may reduce feelings of anxiety and stress, and young people may b.
NIOSH Science Blog: Drugs
SEPTEMBER 3, 2024
What does safety have to do with forest engineering? Everything. For the first time, Safety, Health, and Workforce Development was highlighted as a distinct track at the Council of Forest Engineering’s (COFE) Annual Meeting. Hosted by the University of Idaho’s College of Natural Resources and the University of Idaho Experimental Forest on May 21-24 in Moscow, Idaho, and co-sponsored by the NIOSH Agricultural Center, Pacific Northwest Agricultural Safety and Health (PNASH) Center, the meeting inc
BioPharma Drive: Drug Pricing
SEPTEMBER 3, 2024
The sequencing firm will avoid a penalty of 432 million euros after a court ruled the European Commission did not have jurisdiction to challenge the company’s Grail acquisition.
Alta Sciences
SEPTEMBER 3, 2024
Getting to the Heart of Science With Talita Conte blussier Tue, 09/03/2024 - 15:27 HTML The Stories That Inspire Meet Talita Conte, one of our dedicated scientific project managers. From São Paulo to Montréal, her journey is a testament to the power of passion and innovation in science. After making a breakthrough in myotonic dystrophy type 1 published in Nature Communications, she transitioned to project management at Altasciences, where she continues to drive fast-paced, impactful clinical tri
Perficient: Drug Development
SEPTEMBER 3, 2024
The world of Digital Marketing is challenging and always updating with new strategies. To stay on top of the competition, businesses need to leverage the latest technologies like Generative AI. Gen AI can pump up your digital marketing efforts by creating highly engaged SEO-friendly content and boost your brand on SERP (Search Engine Result Page). In this blog, we’ll get to know what Generative AI is, how it works, and steps for using it in your digital marketing strategies.
Drug Channels
SEPTEMBER 3, 2024
The Healthcare Innovation Company's Value-Based Care Summit In-Person Event | October 28 - 29, 2024 in Washington, DC Use promo code VBCDC to save $100. Register Today. Download the brochure. The Value-Based Care Summit , produced by The Healthcare Innovation Company (thINc), brings together healthcare providers, health plans, pharmaceutical companies/manufacturers, and regulatory and legislative leaders to discuss novel approaches, innovative models, and mutually beneficial partnerships that dr
Perficient: Drug Development
SEPTEMBER 3, 2024
In the wake of VMware’s recent license cost increase under Broadcom’s new pricing model, many enterprises are facing the pressing need to reevaluate their IT strategies. For those reliant on VMware’s virtualization technologies, the cost hike poses a significant challenge to maintaining budgetary control while continuing to drive digital transformation efforts.
BioPharma Drive: Drug Pricing
SEPTEMBER 3, 2024
Following a recent listening session hosted by the agency, current and former members have weighed in on the process and how it could be improved.
Perficient: Drug Development
SEPTEMBER 3, 2024
Relationships are Everything After engaging with numerous organizations seeking to establish efficient and effective data leadership practices, a recurring theme has emerged: executive data leaders often struggle to effectively partner with business teams. Additionally, our research indicates that data leaders who prioritize collaboration with business teams are over 20% more efficient in helping to accomplish organizational goals.
Alta Sciences
SEPTEMBER 3, 2024
Resources_thumbnail_The-Altascientist-36 ehdem Tue, 09/03/2024 - 14:04 Image Resources_thumbnail_The-Altascientist-36.
Perficient: Drug Development
SEPTEMBER 3, 2024
Edge Delivery Services empowers developers and authors to create lightning-fast, high-performing digital experiences that score a perfect 100% on Google’s Lighthouse metrics. With Edge Delivery, you can choose from two flexible implementation options – document-based authoring and WYSIWYT (What You See Is What You Get) – to streamline your development workflow and accelerate content authoring.
Perficient: Drug Development
SEPTEMBER 3, 2024
Expert insights. Personalized for you.
147 
Let's personalize your content